SB 3072

  • Hawaii Senate Bill
  • 2018 Regular Session
  • Introduced in Senate Jan 24, 2018
  • Senate
  • House
  • Governor

Relating To Pharmacy Benefit Managers.

Abstract

Requires pharmacy benefit managers to notify contracting pharmacies of changes to maximum allowable costs by the National Drug Code fifteen days prior to the change. Requires pharmacy benefit managers to disclose where an equivalent drug can be obtained at or below the maximum allowable cost, when a maximum allowable cost appeal is upheld on appeal. Requires pharmacy benefit managers to: allow contracting pharmacies to reverse and rebill claims if the pharmacy benefit manager establishes a maximum allowable cost that is denied on appeal; and pay the difference to the contracting pharmacies. Permits contracting pharmacies to decline to dispense a drug if the reimbursement is less than the acquisition cost. Permits the insurance commissioner to suspend a pharmacy benefit manager's certification if the manager does not comply with state law. Requires the Department of Health to annually report to the legislature and any other state agency on appeals and disposition.

Bill Sponsors (13)

Votes


No votes to display

Actions


Feb 06, 2018

Senate

The committee on CPH deferred the measure.

Jan 31, 2018

Senate

The committee(s) on CPH has scheduled a public hearing on 02-06-18 9:00AM in conference room 229.

Jan 26, 2018

Senate

Passed First Reading.

Senate

Referred to CPH, WAM.

  • Referral-Committee
Commerce, Consumer Protection, and Health Ways and Means

Jan 24, 2018

Senate

Introduced.

Bill Text

Bill Text Versions Format
SB3072 HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Hawaii State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.